| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catatonia | 33 | 2024 | 181 | 7.210 |
Why?
|
| Psychiatry | 15 | 2022 | 1715 | 1.800 |
Why?
|
| Mind-Body Therapies | 13 | 2022 | 291 | 1.710 |
Why?
|
| Neuropsychiatry | 3 | 2019 | 76 | 1.350 |
Why?
|
| Electroconvulsive Therapy | 8 | 2024 | 502 | 1.300 |
Why?
|
| Neurology | 4 | 2022 | 786 | 1.230 |
Why?
|
| Lorazepam | 9 | 2024 | 155 | 1.130 |
Why?
|
| Psychosomatic Medicine | 4 | 2014 | 72 | 1.100 |
Why?
|
| Fibromyalgia | 2 | 2023 | 407 | 1.060 |
Why?
|
| Anti-Anxiety Agents | 7 | 2012 | 405 | 1.060 |
Why?
|
| Meditation | 7 | 2022 | 257 | 1.050 |
Why?
|
| Stress, Psychological | 23 | 2024 | 4543 | 0.970 |
Why?
|
| Neuroleptic Malignant Syndrome | 3 | 2023 | 74 | 0.970 |
Why?
|
| Morphine | 13 | 2008 | 658 | 0.940 |
Why?
|
| Delusions | 3 | 2022 | 301 | 0.890 |
Why?
|
| Relaxation | 7 | 2018 | 51 | 0.880 |
Why?
|
| Burnout, Professional | 4 | 2021 | 712 | 0.880 |
Why?
|
| Delirium | 12 | 2024 | 1695 | 0.820 |
Why?
|
| Anxiety Disorders | 8 | 2012 | 2754 | 0.760 |
Why?
|
| Prisoners | 2 | 2021 | 315 | 0.720 |
Why?
|
| Mental Disorders | 14 | 2022 | 6876 | 0.710 |
Why?
|
| Antipsychotic Agents | 10 | 2024 | 3080 | 0.680 |
Why?
|
| Health Personnel | 4 | 2021 | 3380 | 0.670 |
Why?
|
| Depressive Disorder, Major | 8 | 2017 | 4819 | 0.660 |
Why?
|
| Psychophysiologic Disorders | 4 | 2014 | 223 | 0.640 |
Why?
|
| Refugees | 2 | 2017 | 612 | 0.640 |
Why?
|
| Depression | 22 | 2022 | 8241 | 0.580 |
Why?
|
| Fatigue | 3 | 2021 | 1555 | 0.560 |
Why?
|
| Adaptation, Psychological | 12 | 2021 | 2663 | 0.550 |
Why?
|
| Auditory Pathways | 1 | 2019 | 238 | 0.550 |
Why?
|
| Resilience, Psychological | 6 | 2022 | 805 | 0.540 |
Why?
|
| Hospitals, General | 5 | 2021 | 807 | 0.540 |
Why?
|
| Psychomotor Agitation | 4 | 2019 | 307 | 0.530 |
Why?
|
| Tinnitus | 1 | 2019 | 197 | 0.520 |
Why?
|
| Empathy | 3 | 2016 | 476 | 0.520 |
Why?
|
| Basal Ganglia | 2 | 2019 | 555 | 0.520 |
Why?
|
| Counterpulsation | 3 | 2002 | 16 | 0.520 |
Why?
|
| Tai Ji | 3 | 2017 | 291 | 0.520 |
Why?
|
| Correspondence as Topic | 1 | 2016 | 34 | 0.510 |
Why?
|
| Needs Assessment | 2 | 2017 | 1142 | 0.500 |
Why?
|
| Myocardial Infarction | 9 | 2010 | 11516 | 0.490 |
Why?
|
| Religion and Psychology | 2 | 2015 | 180 | 0.480 |
Why?
|
| Humans | 206 | 2024 | 768393 | 0.480 |
Why?
|
| Grief | 2 | 2022 | 255 | 0.480 |
Why?
|
| Veterans | 4 | 2021 | 2671 | 0.470 |
Why?
|
| Auditory Cortex | 1 | 2019 | 365 | 0.470 |
Why?
|
| Opioid Peptides | 7 | 2017 | 37 | 0.470 |
Why?
|
| Thalamus | 2 | 2019 | 1050 | 0.470 |
Why?
|
| Muscle Relaxants, Central | 1 | 2014 | 93 | 0.450 |
Why?
|
| Affective Symptoms | 5 | 2018 | 418 | 0.450 |
Why?
|
| Benzodiazepines | 7 | 2024 | 1139 | 0.440 |
Why?
|
| Neurosciences | 1 | 2018 | 385 | 0.430 |
Why?
|
| Relaxation Therapy | 5 | 2018 | 181 | 0.420 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 905 | 0.420 |
Why?
|
| Family Practice | 1 | 2016 | 511 | 0.420 |
Why?
|
| Psychotic Disorders | 9 | 2024 | 3279 | 0.420 |
Why?
|
| Receptors, Opioid, mu | 6 | 2008 | 171 | 0.410 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2017 | 1990 | 0.410 |
Why?
|
| Cognition | 6 | 2024 | 7075 | 0.410 |
Why?
|
| Gyrus Cinguli | 1 | 2019 | 1137 | 0.400 |
Why?
|
| Granulocytes | 4 | 1998 | 550 | 0.400 |
Why?
|
| Limbic Encephalitis | 1 | 2012 | 36 | 0.400 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2013 | 98 | 0.390 |
Why?
|
| Adenovirus Infections, Human | 1 | 2012 | 76 | 0.390 |
Why?
|
| Program Development | 2 | 2020 | 1298 | 0.380 |
Why?
|
| Models, Psychological | 4 | 2024 | 828 | 0.380 |
Why?
|
| Mentors | 3 | 2015 | 672 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2011 | 2258 | 0.370 |
Why?
|
| Personality Inventory | 5 | 2010 | 1018 | 0.370 |
Why?
|
| Nervous System Diseases | 6 | 2019 | 1664 | 0.360 |
Why?
|
| Clozapine | 3 | 2023 | 508 | 0.360 |
Why?
|
| Depressive Disorder | 8 | 2018 | 3736 | 0.360 |
Why?
|
| GABA Modulators | 2 | 2010 | 109 | 0.360 |
Why?
|
| Physician's Role | 2 | 2016 | 926 | 0.350 |
Why?
|
| Capacity Building | 2 | 2016 | 265 | 0.350 |
Why?
|
| Anxiety | 13 | 2022 | 4677 | 0.350 |
Why?
|
| Nitric Oxide | 11 | 2013 | 2144 | 0.340 |
Why?
|
| Encephalitis | 2 | 2015 | 441 | 0.320 |
Why?
|
| Stress, Physiological | 9 | 2013 | 1410 | 0.310 |
Why?
|
| Yoga | 3 | 2022 | 280 | 0.310 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2008 | 59 | 0.300 |
Why?
|
| Haloperidol | 3 | 2010 | 394 | 0.300 |
Why?
|
| Loneliness | 2 | 2021 | 211 | 0.300 |
Why?
|
| Hospitalization | 8 | 2024 | 10844 | 0.290 |
Why?
|
| Pilot Projects | 14 | 2021 | 8731 | 0.290 |
Why?
|
| Syria | 2 | 2017 | 86 | 0.280 |
Why?
|
| Mental Health | 7 | 2022 | 3276 | 0.280 |
Why?
|
| Anticonvulsants | 1 | 2017 | 1923 | 0.280 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2017 | 6034 | 0.270 |
Why?
|
| Female | 94 | 2024 | 397089 | 0.270 |
Why?
|
| Neuroimmunomodulation | 3 | 2008 | 188 | 0.270 |
Why?
|
| Lebanon | 2 | 2017 | 245 | 0.270 |
Why?
|
| Male | 90 | 2024 | 364902 | 0.270 |
Why?
|
| Nerve Net | 1 | 2019 | 2362 | 0.270 |
Why?
|
| Propofol | 1 | 2012 | 608 | 0.260 |
Why?
|
| Motivation | 3 | 2021 | 2029 | 0.260 |
Why?
|
| Object Attachment | 3 | 2018 | 333 | 0.260 |
Why?
|
| Conversion Disorder | 2 | 2020 | 202 | 0.260 |
Why?
|
| Mental Health Services | 2 | 2012 | 1731 | 0.260 |
Why?
|
| Psychiatric Department, Hospital | 1 | 2006 | 133 | 0.250 |
Why?
|
| Antidepressive Agents | 3 | 2011 | 2913 | 0.250 |
Why?
|
| Health Services Accessibility | 3 | 2022 | 5512 | 0.250 |
Why?
|
| Internship and Residency | 4 | 2021 | 5949 | 0.240 |
Why?
|
| Bradycardia | 1 | 2007 | 305 | 0.240 |
Why?
|
| Cooperative Behavior | 3 | 2016 | 1515 | 0.240 |
Why?
|
| Monocytes | 4 | 1998 | 2595 | 0.240 |
Why?
|
| Diazepam | 4 | 2024 | 214 | 0.230 |
Why?
|
| Middle Aged | 55 | 2024 | 223491 | 0.230 |
Why?
|
| Angina Pectoris | 2 | 2001 | 960 | 0.230 |
Why?
|
| Movement Disorders | 2 | 2018 | 464 | 0.230 |
Why?
|
| Interdisciplinary Communication | 1 | 2010 | 937 | 0.230 |
Why?
|
| Deception | 2 | 1995 | 100 | 0.230 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 1188 | 0.230 |
Why?
|
| Hyperparathyroidism | 1 | 2005 | 339 | 0.220 |
Why?
|
| Referral and Consultation | 6 | 2022 | 3627 | 0.220 |
Why?
|
| Severity of Illness Index | 12 | 2024 | 15939 | 0.220 |
Why?
|
| Adult | 65 | 2024 | 223640 | 0.220 |
Why?
|
| Placebo Effect | 2 | 2005 | 518 | 0.220 |
Why?
|
| International Cooperation | 2 | 2012 | 1438 | 0.220 |
Why?
|
| Immune System | 4 | 2017 | 801 | 0.210 |
Why?
|
| Coma | 1 | 2007 | 487 | 0.210 |
Why?
|
| Enkephalins | 3 | 2005 | 139 | 0.210 |
Why?
|
| Receptors, Opioid | 3 | 2017 | 145 | 0.210 |
Why?
|
| Mass Screening | 5 | 2020 | 5451 | 0.200 |
Why?
|
| Hypercalcemia | 1 | 2005 | 423 | 0.200 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 1447 | 0.200 |
Why?
|
| Hallucinations | 2 | 2022 | 375 | 0.200 |
Why?
|
| Sick Role | 4 | 1995 | 229 | 0.200 |
Why?
|
| Brain Diseases | 2 | 2022 | 1552 | 0.200 |
Why?
|
| Social Support | 5 | 2019 | 2191 | 0.200 |
Why?
|
| Invertebrates | 2 | 2002 | 55 | 0.200 |
Why?
|
| History, 20th Century | 4 | 2016 | 2771 | 0.200 |
Why?
|
| Developing Countries | 3 | 2018 | 2903 | 0.200 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2017 | 2202 | 0.200 |
Why?
|
| Quinolones | 1 | 2005 | 382 | 0.200 |
Why?
|
| Humanism | 2 | 1993 | 85 | 0.200 |
Why?
|
| Electroencephalography | 8 | 2024 | 6317 | 0.200 |
Why?
|
| Fear | 2 | 2023 | 1494 | 0.200 |
Why?
|
| Akinetic Mutism | 1 | 2021 | 11 | 0.190 |
Why?
|
| Dopamine | 4 | 2005 | 1617 | 0.190 |
Why?
|
| Narcotics | 3 | 2005 | 334 | 0.190 |
Why?
|
| Social Adjustment | 3 | 2003 | 636 | 0.190 |
Why?
|
| Dyskinesias | 1 | 2022 | 79 | 0.190 |
Why?
|
| Psychopharmacology | 1 | 2023 | 146 | 0.190 |
Why?
|
| Music Therapy | 3 | 2013 | 111 | 0.190 |
Why?
|
| Hostility | 2 | 1999 | 185 | 0.190 |
Why?
|
| Nervous System Physiological Phenomena | 3 | 2001 | 115 | 0.180 |
Why?
|
| Syndrome | 4 | 2023 | 3275 | 0.180 |
Why?
|
| Middle East | 2 | 2019 | 233 | 0.180 |
Why?
|
| Research Personnel | 2 | 2016 | 590 | 0.180 |
Why?
|
| Interpersonal Relations | 2 | 2019 | 1440 | 0.180 |
Why?
|
| Pandemics | 7 | 2021 | 8753 | 0.180 |
Why?
|
| Psychological Techniques | 1 | 2020 | 48 | 0.180 |
Why?
|
| Blood Cell Count | 2 | 2013 | 402 | 0.170 |
Why?
|
| Aged | 35 | 2024 | 171562 | 0.170 |
Why?
|
| Ileus | 1 | 2020 | 66 | 0.170 |
Why?
|
| Limbic System | 3 | 2017 | 423 | 0.170 |
Why?
|
| Diagnosis, Differential | 9 | 2012 | 13020 | 0.170 |
Why?
|
| Military Personnel | 2 | 2019 | 1266 | 0.160 |
Why?
|
| Somatoform Disorders | 2 | 2018 | 425 | 0.160 |
Why?
|
| Ethiopia | 2 | 2012 | 482 | 0.160 |
Why?
|
| Telemedicine | 3 | 2022 | 3107 | 0.160 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 285 | 0.150 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3118 | 0.150 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3241 | 0.150 |
Why?
|
| Inpatients | 6 | 2024 | 2570 | 0.150 |
Why?
|
| Brain | 11 | 2024 | 27454 | 0.150 |
Why?
|
| Endophenotypes | 1 | 2020 | 258 | 0.150 |
Why?
|
| Sensation Disorders | 1 | 2019 | 160 | 0.150 |
Why?
|
| Social Isolation | 2 | 2012 | 369 | 0.150 |
Why?
|
| Students | 2 | 2020 | 1744 | 0.150 |
Why?
|
| Histiocytic Sarcoma | 1 | 1997 | 40 | 0.140 |
Why?
|
| Disease | 2 | 1993 | 673 | 0.140 |
Why?
|
| Vertebrates | 1 | 1998 | 227 | 0.140 |
Why?
|
| Primary Health Care | 3 | 2010 | 4748 | 0.140 |
Why?
|
| Labor, Induced | 1 | 2018 | 156 | 0.140 |
Why?
|
| Attitude to Health | 4 | 2002 | 2025 | 0.130 |
Why?
|
| Psychophysiology | 3 | 2001 | 137 | 0.130 |
Why?
|
| Health Resources | 3 | 2020 | 950 | 0.130 |
Why?
|
| Individuality | 1 | 2018 | 307 | 0.130 |
Why?
|
| Academic Medical Centers | 2 | 2011 | 2783 | 0.130 |
Why?
|
| Dissociative Disorders | 1 | 2018 | 235 | 0.130 |
Why?
|
| Vitamin D Deficiency | 1 | 2005 | 1389 | 0.130 |
Why?
|
| Altruism | 1 | 2017 | 212 | 0.130 |
Why?
|
| Health Status | 4 | 2017 | 4094 | 0.120 |
Why?
|
| Job Satisfaction | 1 | 2019 | 549 | 0.120 |
Why?
|
| History, 21st Century | 2 | 2015 | 1575 | 0.120 |
Why?
|
| Neurosecretory Systems | 1 | 2017 | 223 | 0.120 |
Why?
|
| Chronic Disease | 4 | 2020 | 9379 | 0.120 |
Why?
|
| Health Education | 1 | 2002 | 1057 | 0.120 |
Why?
|
| Neutropenia | 1 | 2020 | 893 | 0.120 |
Why?
|
| Language Disorders | 2 | 1986 | 140 | 0.120 |
Why?
|
| Piperazines | 1 | 2005 | 2552 | 0.120 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2018 | 301 | 0.120 |
Why?
|
| Pain | 5 | 2019 | 5103 | 0.120 |
Why?
|
| Cathexis | 1 | 1994 | 3 | 0.120 |
Why?
|
| General Adaptation Syndrome | 1 | 1994 | 7 | 0.110 |
Why?
|
| Personality | 1 | 2018 | 560 | 0.110 |
Why?
|
| Environment | 1 | 2020 | 1124 | 0.110 |
Why?
|
| Psychometrics | 5 | 2018 | 3069 | 0.110 |
Why?
|
| Endothelium, Vascular | 4 | 2000 | 4427 | 0.110 |
Why?
|
| Psychology | 2 | 1993 | 355 | 0.110 |
Why?
|
| Forecasting | 3 | 2010 | 2948 | 0.110 |
Why?
|
| Treatment Outcome | 15 | 2024 | 65379 | 0.110 |
Why?
|
| Fellowships and Scholarships | 2 | 2015 | 1133 | 0.110 |
Why?
|
| Prospective Studies | 13 | 2024 | 54920 | 0.110 |
Why?
|
| Neuropsychological Tests | 6 | 2017 | 7145 | 0.110 |
Why?
|
| Seizures | 3 | 2022 | 3000 | 0.110 |
Why?
|
| Quality of Life | 6 | 2021 | 13503 | 0.110 |
Why?
|
| United States | 13 | 2024 | 73150 | 0.110 |
Why?
|
| Schizophrenia, Paranoid | 3 | 2009 | 103 | 0.110 |
Why?
|
| Amygdala | 2 | 2020 | 1382 | 0.110 |
Why?
|
| Workplace | 1 | 2019 | 872 | 0.110 |
Why?
|
| Microglia | 2 | 2019 | 1374 | 0.100 |
Why?
|
| Mind-Body Relations, Metaphysical | 2 | 2010 | 36 | 0.100 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 39407 | 0.100 |
Why?
|
| Haiti | 1 | 2014 | 553 | 0.100 |
Why?
|
| Cytokines | 4 | 2023 | 7445 | 0.100 |
Why?
|
| Leukemia, Prolymphocytic, T-Cell | 1 | 2012 | 23 | 0.100 |
Why?
|
| Prevalence | 8 | 2019 | 15872 | 0.100 |
Why?
|
| Macrophages | 3 | 2001 | 5796 | 0.100 |
Why?
|
| Coronary Disease | 3 | 2000 | 5924 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2022 | 1959 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 1014 | 0.100 |
Why?
|
| Rwanda | 1 | 2014 | 669 | 0.100 |
Why?
|
| Schizophrenia | 5 | 2020 | 6987 | 0.100 |
Why?
|
| Allostasis | 1 | 2013 | 77 | 0.100 |
Why?
|
| Friends | 1 | 2013 | 149 | 0.100 |
Why?
|
| Fatal Outcome | 2 | 2012 | 1837 | 0.100 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8562 | 0.100 |
Why?
|
| Herpesvirus 6, Human | 1 | 2012 | 98 | 0.100 |
Why?
|
| Professional-Family Relations | 1 | 2016 | 501 | 0.100 |
Why?
|
| Comorbidity | 3 | 2018 | 10588 | 0.100 |
Why?
|
| International Educational Exchange | 1 | 2011 | 54 | 0.090 |
Why?
|
| Substance-Related Disorders | 5 | 2017 | 4429 | 0.090 |
Why?
|
| Irritable Mood | 1 | 1993 | 196 | 0.090 |
Why?
|
| Psychotherapy | 1 | 2020 | 1656 | 0.090 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 7861 | 0.090 |
Why?
|
| Inflammation | 4 | 2023 | 10863 | 0.090 |
Why?
|
| Feasibility Studies | 4 | 2022 | 5313 | 0.090 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2009 | 705 | 0.090 |
Why?
|
| Physician-Patient Relations | 4 | 2003 | 3267 | 0.090 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 1994 | 360 | 0.090 |
Why?
|
| Decision Making | 2 | 2024 | 3953 | 0.090 |
Why?
|
| Dopamine Agents | 1 | 2011 | 190 | 0.090 |
Why?
|
| Biological Evolution | 5 | 2017 | 1078 | 0.090 |
Why?
|
| Creatine Kinase | 1 | 2013 | 685 | 0.090 |
Why?
|
| Pregnant Women | 1 | 2015 | 577 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 985 | 0.090 |
Why?
|
| Anxiety, Separation | 2 | 2005 | 86 | 0.090 |
Why?
|
| Crime | 2 | 2020 | 206 | 0.090 |
Why?
|
| South Australia | 1 | 2010 | 27 | 0.090 |
Why?
|
| Emotions | 3 | 2021 | 2768 | 0.090 |
Why?
|
| Heart Arrest | 2 | 1994 | 1516 | 0.090 |
Why?
|
| Megacolon, Toxic | 1 | 2009 | 8 | 0.090 |
Why?
|
| Professional Staff Committees | 1 | 2009 | 37 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 1993 | 594 | 0.090 |
Why?
|
| Electronic Mail | 1 | 2011 | 215 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2740 | 0.080 |
Why?
|
| Energy Metabolism | 2 | 2013 | 2906 | 0.080 |
Why?
|
| Patient Selection | 1 | 2022 | 4266 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 2 | 1996 | 3681 | 0.080 |
Why?
|
| Pituitary-Adrenal System | 2 | 2008 | 557 | 0.080 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 454 | 0.080 |
Why?
|
| Japan | 1 | 2014 | 1418 | 0.080 |
Why?
|
| Amantadine | 2 | 2024 | 59 | 0.080 |
Why?
|
| Self-Injurious Behavior | 1 | 2015 | 568 | 0.080 |
Why?
|
| History, 19th Century | 2 | 2015 | 715 | 0.080 |
Why?
|
| Oxytocin | 2 | 2009 | 403 | 0.080 |
Why?
|
| Videoconferencing | 1 | 2011 | 209 | 0.080 |
Why?
|
| Cyclophosphamide | 2 | 1997 | 2226 | 0.080 |
Why?
|
| Peptide Fragments | 2 | 2000 | 5151 | 0.080 |
Why?
|
| Electric Countershock | 2 | 1989 | 534 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2008 | 15881 | 0.080 |
Why?
|
| Serotonin Antagonists | 1 | 2009 | 147 | 0.080 |
Why?
|
| Cesarean Section | 1 | 2018 | 1417 | 0.080 |
Why?
|
| Family | 4 | 2013 | 3208 | 0.080 |
Why?
|
| Reward | 2 | 2007 | 984 | 0.080 |
Why?
|
| Pregnancy Complications | 2 | 2018 | 2972 | 0.080 |
Why?
|
| Amitriptyline | 1 | 1989 | 112 | 0.080 |
Why?
|
| Community Health Services | 1 | 2014 | 659 | 0.080 |
Why?
|
| Puerperal Disorders | 2 | 2018 | 303 | 0.080 |
Why?
|
| Movement | 1 | 2015 | 1490 | 0.080 |
Why?
|
| Tachycardia, Sinus | 1 | 2008 | 43 | 0.080 |
Why?
|
| Models, Biological | 4 | 2007 | 9493 | 0.080 |
Why?
|
| Societies, Scientific | 1 | 2009 | 223 | 0.080 |
Why?
|
| Tacrolimus | 1 | 2012 | 750 | 0.080 |
Why?
|
| Hippocampus | 3 | 2012 | 3784 | 0.080 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2008 | 205 | 0.080 |
Why?
|
| Coronary Care Units | 1 | 2010 | 235 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 2276 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 2 | 1992 | 2491 | 0.070 |
Why?
|
| Serotonin | 1 | 1993 | 1045 | 0.070 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 549 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 266 | 0.070 |
Why?
|
| Motor Activity | 1 | 2018 | 2720 | 0.070 |
Why?
|
| Gastrointestinal Motility | 1 | 2009 | 236 | 0.070 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 1988 | 44 | 0.070 |
Why?
|
| Life Change Events | 1 | 1993 | 962 | 0.070 |
Why?
|
| Burning Mouth Syndrome | 1 | 2007 | 25 | 0.070 |
Why?
|
| Self Care | 1 | 2013 | 797 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2010 | 242 | 0.070 |
Why?
|
| Mental Status Schedule | 1 | 2008 | 315 | 0.070 |
Why?
|
| Down-Regulation | 4 | 2007 | 2940 | 0.070 |
Why?
|
| Academies and Institutes | 1 | 2009 | 326 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 10377 | 0.070 |
Why?
|
| Lymphocytosis | 1 | 2008 | 121 | 0.070 |
Why?
|
| Alcohols | 1 | 2007 | 94 | 0.070 |
Why?
|
| Signal Transduction | 6 | 2017 | 23631 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2007 | 108 | 0.070 |
Why?
|
| Panic Disorder | 2 | 2004 | 613 | 0.070 |
Why?
|
| Animals | 22 | 2018 | 169337 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2862 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 863 | 0.070 |
Why?
|
| Neurotransmitter Agents | 3 | 1996 | 665 | 0.070 |
Why?
|
| Behavior Therapy | 3 | 2001 | 886 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 600 | 0.070 |
Why?
|
| Death, Sudden | 2 | 1986 | 301 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2007 | 168 | 0.070 |
Why?
|
| Professional Competence | 1 | 2009 | 430 | 0.070 |
Why?
|
| Diabetes Insipidus | 1 | 1987 | 144 | 0.070 |
Why?
|
| Aspirin | 1 | 1998 | 3135 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2017 | 3131 | 0.070 |
Why?
|
| Compulsive Behavior | 1 | 1987 | 117 | 0.070 |
Why?
|
| Adolescent | 10 | 2024 | 89184 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 1999 | 3801 | 0.070 |
Why?
|
| Autistic Disorder | 2 | 2011 | 1240 | 0.060 |
Why?
|
| Caregivers | 1 | 2018 | 2303 | 0.060 |
Why?
|
| Internationality | 1 | 2011 | 1008 | 0.060 |
Why?
|
| Drug Resistance | 2 | 2011 | 1595 | 0.060 |
Why?
|
| Education, Medical | 3 | 2011 | 1742 | 0.060 |
Why?
|
| Dementia | 2 | 2008 | 2729 | 0.060 |
Why?
|
| Recurrence | 2 | 2008 | 8506 | 0.060 |
Why?
|
| Drinking | 1 | 1987 | 197 | 0.060 |
Why?
|
| Biomedical Research | 2 | 2015 | 3464 | 0.060 |
Why?
|
| Outpatients | 1 | 2014 | 1604 | 0.060 |
Why?
|
| Child Behavior | 1 | 2011 | 865 | 0.060 |
Why?
|
| Paracrine Communication | 1 | 2007 | 278 | 0.060 |
Why?
|
| Alcoholism | 2 | 2008 | 1982 | 0.060 |
Why?
|
| Suicidal Ideation | 1 | 2015 | 1462 | 0.060 |
Why?
|
| Peripheral Nervous System | 1 | 2006 | 151 | 0.060 |
Why?
|
| Bulimia | 1 | 1988 | 405 | 0.060 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2007 | 251 | 0.060 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 26375 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2008 | 6409 | 0.060 |
Why?
|
| Defibrillators, Implantable | 1 | 1994 | 1498 | 0.060 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 11918 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 545 | 0.060 |
Why?
|
| Medicine in Literature | 1 | 1985 | 32 | 0.060 |
Why?
|
| Brain Mapping | 3 | 2012 | 6740 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 481 | 0.060 |
Why?
|
| Neurologic Examination | 1 | 2008 | 916 | 0.060 |
Why?
|
| Huntington Disease | 1 | 2011 | 1147 | 0.060 |
Why?
|
| Suicide | 1 | 2015 | 1607 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 2 | 2001 | 941 | 0.060 |
Why?
|
| Basal Ganglia Diseases | 1 | 1985 | 145 | 0.060 |
Why?
|
| Role | 1 | 1985 | 176 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2709 | 0.060 |
Why?
|
| Culture | 2 | 2005 | 623 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2009 | 1420 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2002 | 2170 | 0.060 |
Why?
|
| Frontal Lobe | 2 | 2008 | 1428 | 0.060 |
Why?
|
| Massachusetts | 3 | 2015 | 8902 | 0.050 |
Why?
|
| Memantine | 1 | 2024 | 111 | 0.050 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2008 | 628 | 0.050 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 5831 | 0.050 |
Why?
|
| Risk Factors | 7 | 2024 | 74962 | 0.050 |
Why?
|
| Curriculum | 2 | 2014 | 3776 | 0.050 |
Why?
|
| Attention | 2 | 2006 | 2425 | 0.050 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1989 | 716 | 0.050 |
Why?
|
| Juvenile Delinquency | 1 | 2003 | 116 | 0.050 |
Why?
|
| Young Adult | 9 | 2024 | 60049 | 0.050 |
Why?
|
| Schizophrenic Psychology | 2 | 1987 | 1652 | 0.050 |
Why?
|
| Narcissism | 1 | 1983 | 64 | 0.050 |
Why?
|
| Analgesics, Opioid | 2 | 2003 | 3836 | 0.050 |
Why?
|
| Internet | 2 | 2012 | 3107 | 0.050 |
Why?
|
| Dracunculus Nematode | 1 | 2002 | 9 | 0.050 |
Why?
|
| Bipolar Disorder | 3 | 2020 | 5126 | 0.050 |
Why?
|
| Psychotropic Drugs | 1 | 2008 | 884 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2020 | 24318 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2018 | 8541 | 0.050 |
Why?
|
| Nicotine | 1 | 2007 | 680 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 4641 | 0.050 |
Why?
|
| Mood Disorders | 1 | 1989 | 1129 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2014 | 3231 | 0.050 |
Why?
|
| Cocaine | 1 | 2007 | 960 | 0.050 |
Why?
|
| Ethanol | 1 | 2008 | 1332 | 0.050 |
Why?
|
| Overweight | 1 | 2013 | 2445 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2006 | 696 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3407 | 0.050 |
Why?
|
| Attitude to Death | 1 | 1985 | 401 | 0.050 |
Why?
|
| Pregnancy | 6 | 2018 | 30200 | 0.050 |
Why?
|
| N-Methylaspartate | 1 | 2022 | 231 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2412 | 0.050 |
Why?
|
| Protein Precursors | 3 | 2005 | 1134 | 0.050 |
Why?
|
| Weight Loss | 1 | 2013 | 2713 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2008 | 2268 | 0.050 |
Why?
|
| Chest Pain | 1 | 2008 | 1099 | 0.050 |
Why?
|
| Colon | 1 | 2009 | 1805 | 0.050 |
Why?
|
| Hydrocortisone | 4 | 2008 | 1841 | 0.050 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 350 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1879 | 0.050 |
Why?
|
| Age Distribution | 2 | 2018 | 2877 | 0.050 |
Why?
|
| Schistosoma mansoni | 1 | 2002 | 156 | 0.050 |
Why?
|
| Psychological Theory | 1 | 2002 | 175 | 0.050 |
Why?
|
| Enkephalin, Methionine | 2 | 2000 | 26 | 0.050 |
Why?
|
| Diseases in Twins | 1 | 1983 | 447 | 0.050 |
Why?
|
| Leukopoiesis | 1 | 2020 | 54 | 0.040 |
Why?
|
| Terminally Ill | 2 | 1993 | 240 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2442 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2023 | 443 | 0.040 |
Why?
|
| Stroke | 1 | 2022 | 9742 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 3486 | 0.040 |
Why?
|
| Child | 7 | 2024 | 80891 | 0.040 |
Why?
|
| Age Factors | 2 | 2024 | 18471 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2024 | 41795 | 0.040 |
Why?
|
| Sleep | 1 | 2015 | 4802 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 17626 | 0.040 |
Why?
|
| Drug Tolerance | 2 | 2005 | 366 | 0.040 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2001 | 217 | 0.040 |
Why?
|
| Cardiovascular Diseases | 4 | 2020 | 15649 | 0.040 |
Why?
|
| Anger | 2 | 1994 | 405 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2024 | 81801 | 0.040 |
Why?
|
| Models, Neurological | 2 | 2005 | 1783 | 0.040 |
Why?
|
| Marital Status | 1 | 2001 | 426 | 0.040 |
Why?
|
| Median Eminence | 1 | 1999 | 28 | 0.040 |
Why?
|
| Aged, 80 and over | 8 | 2022 | 59686 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2006 | 1346 | 0.040 |
Why?
|
| Hypertension | 2 | 2018 | 8615 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2002 | 619 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2005 | 2750 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6085 | 0.040 |
Why?
|
| Patient Dropouts | 1 | 2001 | 411 | 0.040 |
Why?
|
| Insulin | 1 | 2013 | 6607 | 0.040 |
Why?
|
| Fetal Distress | 1 | 2018 | 40 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2022 | 549 | 0.040 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 284 | 0.040 |
Why?
|
| Plasma Exchange | 1 | 2019 | 160 | 0.040 |
Why?
|
| Noise | 1 | 2020 | 292 | 0.040 |
Why?
|
| Self Concept | 2 | 1995 | 1047 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2011 | 2192 | 0.040 |
Why?
|
| Wound Healing | 1 | 2009 | 2813 | 0.040 |
Why?
|
| Parent-Child Relations | 2 | 1993 | 774 | 0.040 |
Why?
|
| Trust | 1 | 2003 | 532 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6318 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2019 | 387 | 0.040 |
Why?
|
| Neurosecretion | 1 | 2017 | 10 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 1985 | 1280 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2024 | 36849 | 0.040 |
Why?
|
| Fetal Macrosomia | 1 | 2018 | 138 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1997 | 187 | 0.040 |
Why?
|
| Protozoan Infections | 1 | 2017 | 38 | 0.040 |
Why?
|
| Base Sequence | 1 | 2008 | 12422 | 0.030 |
Why?
|
| Patient Care | 2 | 1993 | 629 | 0.030 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2018 | 139 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5375 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 1753 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2010 | 2819 | 0.030 |
Why?
|
| Abruptio Placentae | 1 | 2018 | 118 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2024 | 42650 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2000 | 962 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3707 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2019 | 751 | 0.030 |
Why?
|
| Psychoneuroimmunology | 1 | 1996 | 13 | 0.030 |
Why?
|
| Morbidity | 1 | 2022 | 1758 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 1890 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 2 | 2002 | 1094 | 0.030 |
Why?
|
| Vasculitis | 1 | 2020 | 524 | 0.030 |
Why?
|
| Arteriosclerosis | 2 | 2002 | 1056 | 0.030 |
Why?
|
| Prisons | 1 | 2018 | 178 | 0.030 |
Why?
|
| Critical Illness | 1 | 2008 | 2755 | 0.030 |
Why?
|
| Psychology, Clinical | 1 | 2015 | 43 | 0.030 |
Why?
|
| Vasomotor System | 1 | 1996 | 208 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2022 | 1203 | 0.030 |
Why?
|
| Human Rights | 1 | 2018 | 312 | 0.030 |
Why?
|
| Saphenous Vein | 1 | 1998 | 519 | 0.030 |
Why?
|
| Rest | 1 | 2000 | 951 | 0.030 |
Why?
|
| Estradiol | 2 | 2000 | 1952 | 0.030 |
Why?
|
| Glucocorticoids | 2 | 2019 | 2168 | 0.030 |
Why?
|
| Stillbirth | 1 | 2018 | 376 | 0.030 |
Why?
|
| Universities | 1 | 2020 | 1005 | 0.030 |
Why?
|
| Training Support | 1 | 2015 | 109 | 0.030 |
Why?
|
| Chemotaxis | 1 | 1997 | 600 | 0.030 |
Why?
|
| Alkaloids | 1 | 1996 | 192 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 303 | 0.030 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1995 | 98 | 0.030 |
Why?
|
| Ethics, Research | 1 | 2016 | 177 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10776 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 1997 | 692 | 0.030 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 273 | 0.030 |
Why?
|
| Rodentia | 1 | 1996 | 262 | 0.030 |
Why?
|
| Cell Size | 1 | 1996 | 626 | 0.030 |
Why?
|
| Breathing Exercises | 1 | 2014 | 59 | 0.030 |
Why?
|
| Headache | 1 | 2022 | 1262 | 0.030 |
Why?
|
| Aggression | 1 | 2019 | 750 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 1989 | 4300 | 0.030 |
Why?
|
| Endorphins | 1 | 1994 | 73 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2018 | 591 | 0.030 |
Why?
|
| Prognosis | 2 | 2008 | 30022 | 0.030 |
Why?
|
| Tegmentum Mesencephali | 1 | 1994 | 59 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 1994 | 318 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1997 | 677 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1997 | 618 | 0.030 |
Why?
|
| Status Epilepticus | 1 | 2019 | 463 | 0.030 |
Why?
|
| Genes, fos | 1 | 1994 | 176 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 2426 | 0.030 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1994 | 121 | 0.030 |
Why?
|
| History, Early Modern 1451-1600 | 1 | 1993 | 3 | 0.030 |
Why?
|
| History, Modern 1601- | 1 | 1993 | 16 | 0.030 |
Why?
|
| Dementia, Multi-Infarct | 1 | 1993 | 10 | 0.030 |
Why?
|
| Shyness | 1 | 1993 | 21 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 7955 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1996 | 660 | 0.030 |
Why?
|
| Perception | 2 | 2001 | 1205 | 0.030 |
Why?
|
| Rats | 4 | 2012 | 23835 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2012 | 2505 | 0.030 |
Why?
|
| Ventricular Fibrillation | 2 | 1986 | 537 | 0.030 |
Why?
|
| History, Medieval | 1 | 1993 | 62 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 708 | 0.030 |
Why?
|
| Neprilysin | 1 | 1996 | 487 | 0.030 |
Why?
|
| AIDS Dementia Complex | 1 | 1994 | 155 | 0.030 |
Why?
|
| MMPI | 1 | 1993 | 81 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1999 | 1149 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2016 | 303 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 1996 | 556 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1994 | 313 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 1996 | 643 | 0.030 |
Why?
|
| History, Ancient | 1 | 1993 | 213 | 0.030 |
Why?
|
| Guilt | 1 | 1993 | 95 | 0.030 |
Why?
|
| Group Processes | 1 | 2014 | 228 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 457 | 0.020 |
Why?
|
| Focus Groups | 1 | 2018 | 1453 | 0.020 |
Why?
|
| Carbidopa | 1 | 2011 | 30 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2007 | 12805 | 0.020 |
Why?
|
| Dance Therapy | 1 | 2011 | 8 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3794 | 0.020 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 1993 | 134 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2000 | 2247 | 0.020 |
Why?
|
| Income | 1 | 2020 | 1877 | 0.020 |
Why?
|
| Locus Coeruleus | 1 | 1994 | 243 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1998 | 3102 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2000 | 2194 | 0.020 |
Why?
|
| Social Environment | 2 | 2009 | 1018 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 1993 | 249 | 0.020 |
Why?
|
| Doxorubicin | 1 | 1997 | 2229 | 0.020 |
Why?
|
| Species Specificity | 1 | 1995 | 2417 | 0.020 |
Why?
|
| Levodopa | 1 | 2011 | 223 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 1994 | 521 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2005 | 2895 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1996 | 773 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14737 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1642 | 0.020 |
Why?
|
| Educational Status | 2 | 2013 | 2518 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2000 | 3663 | 0.020 |
Why?
|
| Length of Stay | 1 | 2024 | 6519 | 0.020 |
Why?
|
| Bromocriptine | 1 | 2010 | 93 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5422 | 0.020 |
Why?
|
| Drug Combinations | 2 | 2011 | 2079 | 0.020 |
Why?
|
| Homeostasis | 2 | 2008 | 3349 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2019 | 2126 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1994 | 549 | 0.020 |
Why?
|
| Religion | 1 | 2013 | 377 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8199 | 0.020 |
Why?
|
| Affect | 1 | 2017 | 1501 | 0.020 |
Why?
|
| Time Factors | 5 | 2020 | 40272 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 4571 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2819 | 0.020 |
Why?
|
| Positron-Emission Tomography | 2 | 2019 | 6670 | 0.020 |
Why?
|
| Electrolytes | 1 | 2010 | 278 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2005 | 4848 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2018 | 22296 | 0.020 |
Why?
|
| Fluoxetine | 1 | 1993 | 735 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2000 | 2529 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2022 | 3476 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2017 | 1360 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3906 | 0.020 |
Why?
|
| Life Style | 3 | 2010 | 3929 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2019 | 2990 | 0.020 |
Why?
|
| Cell Communication | 1 | 1996 | 1660 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 9063 | 0.020 |
Why?
|
| Poverty | 1 | 2020 | 2721 | 0.020 |
Why?
|
| Personal Satisfaction | 1 | 1993 | 647 | 0.020 |
Why?
|
| Mammals | 1 | 1994 | 1136 | 0.020 |
Why?
|
| China | 1 | 2014 | 2395 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2009 | 527 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2917 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1994 | 1561 | 0.020 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2007 | 23 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2010 | 353 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1962 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2016 | 1137 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1794 | 0.020 |
Why?
|
| Water Intoxication | 1 | 1987 | 10 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1994 | 1143 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2011 | 6350 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 1585 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 7598 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2010 | 371 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2002 | 4047 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2007 | 262 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 2337 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5794 | 0.020 |
Why?
|
| Suicide, Attempted | 1 | 2015 | 1409 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2695 | 0.020 |
Why?
|
| Checklist | 1 | 2014 | 844 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2009 | 13576 | 0.020 |
Why?
|
| Urban Population | 1 | 2015 | 2045 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 3413 | 0.020 |
Why?
|
| Heart Failure | 1 | 2011 | 11858 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1994 | 1568 | 0.020 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1989 | 273 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2010 | 585 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 2009 | 350 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 1995 | 2433 | 0.020 |
Why?
|
| Amnesia | 1 | 1988 | 258 | 0.020 |
Why?
|
| Schools | 1 | 2015 | 1496 | 0.020 |
Why?
|
| Premature Birth | 1 | 2018 | 1814 | 0.020 |
Why?
|
| Dantrolene | 1 | 1985 | 26 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4528 | 0.020 |
Why?
|
| Disease Progression | 1 | 2022 | 13646 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 1986 | 624 | 0.020 |
Why?
|
| Adjustment Disorders | 1 | 1985 | 68 | 0.020 |
Why?
|
| Medial Forebrain Bundle | 1 | 1985 | 43 | 0.020 |
Why?
|
| Pain Measurement | 1 | 1995 | 3581 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 1997 | 19022 | 0.010 |
Why?
|
| Psychopathology | 1 | 1988 | 435 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 2 | 1999 | 911 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 849 | 0.010 |
Why?
|
| Naloxone | 1 | 2007 | 372 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1983 | 40 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1995 | 3121 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1397 | 0.010 |
Why?
|
| Boston | 2 | 2011 | 9371 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2018 | 5367 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14784 | 0.010 |
Why?
|
| Neoplasms | 1 | 1993 | 22385 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 648 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2056 | 0.010 |
Why?
|
| Abdomen | 1 | 2009 | 1136 | 0.010 |
Why?
|
| Individuation | 1 | 1983 | 23 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1986 | 309 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2011 | 1218 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2009 | 1070 | 0.010 |
Why?
|
| Shock, Septic | 1 | 2009 | 774 | 0.010 |
Why?
|
| Ego | 1 | 1983 | 99 | 0.010 |
Why?
|
| HIV Infections | 1 | 2009 | 17575 | 0.010 |
Why?
|
| Tachycardia | 1 | 1985 | 598 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 1169 | 0.010 |
Why?
|
| Morphine Derivatives | 1 | 2002 | 43 | 0.010 |
Why?
|
| Narcotic Antagonists | 1 | 2007 | 591 | 0.010 |
Why?
|
| Personality Development | 1 | 1983 | 244 | 0.010 |
Why?
|
| Infant | 1 | 2024 | 36510 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 20224 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9510 | 0.010 |
Why?
|
| Public Health | 1 | 2015 | 2682 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1983 | 1379 | 0.010 |
Why?
|
| Saliva | 1 | 2006 | 854 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1993 | 3125 | 0.010 |
Why?
|
| Physicians | 1 | 2019 | 4614 | 0.010 |
Why?
|
| Intelligence | 1 | 2006 | 929 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1986 | 975 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 13423 | 0.010 |
Why?
|
| Micrococcus luteus | 1 | 2000 | 3 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1983 | 472 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 21544 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 267 | 0.010 |
Why?
|
| Coronary Artery Disease | 2 | 2002 | 6567 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2011 | 2693 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 2003 | 253 | 0.010 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2003 | 259 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2005 | 1830 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4588 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1986 | 790 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1895 | 0.010 |
Why?
|
| Mental Recall | 1 | 2006 | 1226 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2000 | 150 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1985 | 1004 | 0.010 |
Why?
|
| Reaction Time | 1 | 2006 | 2103 | 0.010 |
Why?
|
| Mitochondria | 1 | 2013 | 3675 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1989 | 2389 | 0.010 |
Why?
|
| Registries | 1 | 2015 | 8379 | 0.010 |
Why?
|
| Linear Models | 1 | 2009 | 5878 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 388 | 0.010 |
Why?
|
| Leukocytes | 1 | 2007 | 2030 | 0.010 |
Why?
|
| Utilization Review | 1 | 2000 | 384 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4941 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12456 | 0.010 |
Why?
|
| Acute Disease | 1 | 2009 | 7242 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10478 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 6993 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2002 | 1539 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1999 | 320 | 0.010 |
Why?
|
| Mesencephalon | 1 | 2000 | 339 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1999 | 206 | 0.010 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2000 | 342 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1985 | 1486 | 0.010 |
Why?
|
| Health Promotion | 1 | 2010 | 2209 | 0.010 |
Why?
|
| Exercise | 1 | 2014 | 5946 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 1647 | 0.010 |
Why?
|
| Bivalvia | 1 | 1996 | 55 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1893 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2000 | 524 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 10117 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 1999 | 706 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2000 | 968 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2000 | 1158 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 21162 | 0.010 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2005 | 1252 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1983 | 1965 | 0.010 |
Why?
|
| Arteries | 1 | 2000 | 1126 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1890 | 0.010 |
Why?
|
| Age of Onset | 1 | 2002 | 3345 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2010 | 4843 | 0.010 |
Why?
|
| Arousal | 1 | 2000 | 1183 | 0.010 |
Why?
|
| Palliative Care | 1 | 1989 | 3643 | 0.010 |
Why?
|
| Respiration | 1 | 2000 | 1667 | 0.010 |
Why?
|
| Models, Immunological | 1 | 1996 | 518 | 0.010 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1993 | 54 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3587 | 0.010 |
Why?
|
| Risk | 1 | 1985 | 9636 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1985 | 3838 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2000 | 1429 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7463 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2000 | 1398 | 0.010 |
Why?
|
| Obesity | 1 | 2013 | 13084 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 2565 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2000 | 4211 | 0.000 |
Why?
|
| Testosterone | 1 | 1999 | 2493 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 5538 | 0.000 |
Why?
|
| Mice | 1 | 2014 | 82017 | 0.000 |
Why?
|
| Sex Factors | 1 | 2001 | 10654 | 0.000 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 113 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3722 | 0.000 |
Why?
|
| Electrodes, Implanted | 1 | 1989 | 841 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15455 | 0.000 |
Why?
|
| New York | 1 | 1986 | 884 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11854 | 0.000 |
Why?
|
| Biopsy | 1 | 1993 | 6808 | 0.000 |
Why?
|